Causes of Visual Loss in Retinal Disease
- Conditions
- UveitisScleritis
- Interventions
- Drug: Immunosuppressive Agents
- Registration Number
- NCT01613963
- Lead Sponsor
- Royal Surrey County Hospital NHS Foundation Trust
- Brief Summary
This is a study of visual outcomes in retinal disease that seeks to identify the causes of visual loss. This data will be used to predict which patients are at risk of losing vision and how they can be better treated.
- Detailed Description
This is a study of visual outcomes in retinal disease. It is an observational study of patients who have been seen in the retinal clinic, and involves a retrospective casenotes analysis to identify patients who have suffered visual loss and the reason for that visual loss. These data will be analysed to enable the identification of factors that predict visual loss in patients who present earlier in the course of their disease.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2000
- patients with a diagnosis of ocular inflammation
- patients with at least 6 months of follow-up
- patients without a diagnosis of ocular inflammation
- patients with less than 6 months of follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with ocular inflammation Immunosuppressive Agents Patients with ocular inflammation
- Primary Outcome Measures
Name Time Method Visual acuity at 5 years 5 years Best-corrected visual acuity at 5 years
- Secondary Outcome Measures
Name Time Method Visual acuity at 10 years 10 years Best corrected visual acuity at 10 years
Source of referral Baseline Categorised as A\&E/GP referral/Optician referral/Tertiary referral
Laterality Baseline Categorised as:
Right eye/Left eye/BilateralAnatomical diagnosis Baseline Cateogorised as:
Acute anterior uveitis / Chronic anterior uveitis / Fuchs heterochromic cyclitis / Intermediate uveitis / Pars planitis / Posterior Uveitis / Panuveitis / Episcleritis / ScleritisAetiological diagnosis Baseline Diagnosed as:
Viral / Bacterial / Fungal / Parasitic / Inflammatory / MalignantAssociated systemic disease Baseline Any associated systemic disease, e.g. HLA-B27 associated disease, Behcet's disease, multiple sclerosis, Vogt-Koyanagi-Harada syndrome, rheumatoid arthritis, collagen vascular disease, tuberculosis, granulomatosis with polyangiitis
Complications of disease and causes of visual loss at 5 years 5 years Categorised into:
Corneal clarity problems / cataract / vitreous debris / retinal detachment / cystoid macular edema / retinal pigment epithelium atrophy / macular scarring / epiretinal membrane / macular hole / steroid response / glaucoma / other optic neuropathy / hypotony \& phthisis / otherComplications of disease and causes of visual loss at 10 years 10 years Categorised into:
Corneal clarity problems / cataract / vitreous debris / retinal detachment / cystoid macular edema / retinal pigment epithelium atrophy / macular scarring / epiretinal membrane / macular hole / steroid response / glaucoma / other optic neuropathy / hypotony \& phthisis / otherComplications of disease and causes of visual loss Up to 10 years Categorised into:
Corneal clarity problems / cataract / vitreous debris / retinal detachment / cystoid macular edema / retinal pigment epithelium atrophy / macular scarring / epiretinal membrane / macular hole / steroid response / glaucoma / other optic neuropathy / hypotony \& phthisis / otherTreatment measures employed Up to 10 years Categorised into:
Topical treatment / periocular steroid / intraocular steroid / intraocular other agent / Glaucoma treatment / systemic immunosuppressive agentsComplications of disease and treatment Up to 10 years Categorised into:
1. Local complications: Raised intraocular pressure / cataract / endophthalmitis / other
2. Systemic complications: Diabetes / hypertension / cholesterol / liver function / bone density loss / otherSurgical procedures Up to 10 years List and dates of any intraocular surgery performed during the study
Burden of disease - appointments Up to 10 years Number of outpatient appointments over the course of the study
Burden of disease - outpatient procedures Up to 10 years Number of outpatient procedures over the course of the study
Burden of disease - inpatient procedures Up to 10 years Number of inpatient procedures over the course of the study
Blind registration Up to 10 years Year of any registration as partially sighted or blind
Trial Locations
- Locations (2)
Moorfields Eye Hospital
🇬🇧London, United Kingdom
Royal Surrey County Hospital
🇬🇧Guildford, UK, United Kingdom